This scoping review (2022) explores the prevalence, risk factors and pathophysiology of hallucinogen persisting perception disorder (HPPD) among different psychedelics. While HPPD is uncommon, current interest in psychedelic research affords the opportunity to characterize HPPD in its frequency, risk and protective factors, key characteristics, and potential treatments.
- Published
- Journal
- Expert Opinion on Drug Safety
- Authors
- Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., Ceban, F., Jawad, M. Y., McIntyre, R. S., Ho, R.